Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

103 results

Stibbe advises Aedifica

Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands.

Stibbe advises pharmaceutical multinational

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe advises KBC Securities

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Mini-symposium “De accountant – Paard van Troje?”

Op dinsdag 21 mei organiseert de afdeling Corporate Criminal Law & Investigations van Stibbe een mini-symposium rond het thema van de accountant als pseudo-opsporingsambtenaar en de controlecliënt als potentiële verdachte.

Stibbe advises worldwide seeds leader

Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.

Digital Law Up(to)date: No processing of vaccination status in recruitment process

The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated.

Kate Criel

Junior Professional Support Lawyer Brussels

Stibbe StartsUP welcomes Level.Works and continues advising Skoon

After successfully advising EME, Dyme, Hardt Hyperloop and Skoon, Stibbe in Amsterdam is happy to announce that platform startup Level.Works is the latest participant to join the StartsUP programme. 

Stibbe advises Dyme

Stibbe has advised fintech company Dyme on obtaining a PSD2 licence for the provision of Account Information Services (AIS) from the Dutch Central Bank. Dyme is the first independent payment service for consumers in the Netherlands to receive this licence

Le chômage temporaire est-il antidote au coronavirus?

L’ONEM a confirmé que les employeurs peuvent, dans certaines situations, mettre des travailleurs en chômage temporaire pour force majeure en raison du coronavirus.

Stibbe advises Centtrip

Stibbe advises Centtrip, one the UK's premier and most innovative fintech companies, on expanding into the European mainland by setting up a regulated electronic money institution in the Netherlands and its licence application with the Dutch Central Bank.

Dutch national police service liable for unlawful granting of firearms permit

In a recent decision (ECLI:NL:HR:2019:1409), the Supreme Court has decided that the Dutch national police force is liable for damage suffered by victims of a shooting which took place in a shopping centre in 2011; an event that shocked the Netherlands.

Stibbe advises Wright Medical Group

Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group. 

Stibbe advises Aedifica

Stibbe advised Aedifica on its secondary share listing on Euronext Amsterdam. Trading started on 7 November 2019.

Aan de slag met de nieuwe Wet hergebruik van overheidsinformatie

Op 18 juli 2015 is de Wet hergebruik van overheidsinformatie (de "Who") in werking getreden. Burgers en bedrijven kunnen bij publieketaakinstellingen een verzoek indienen tot het verstrekken van overheidsinformatie.

Product counseling en intellectueel eigendom

In deze podcastaflevering van Stibbe Legal Insights spreken Femke van der Voort, gespecialiseerd in intellectueel eigendom, en Paul van der Hulst, mede-eigenaar en managing director van MoviĜo, over het beschermen van intellectuele eigendomsrechten.

Stibbe advises Aedifica

Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Lelystad and the acquisition and lease of a recently completed care residence in Zwolle. 

Breaking news from the CJEU: no SPCs for new therapeutic applications

On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.

Pagination

  • Previous page
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Next page
Reset filters
Date
Content type
  • Article (26)
  • Event (2)
  • Inside Stibbe (5)
  • Matter (48)
  • Podcast (2)
  • People (20)
Expertise
  • (-) Healthcare and Life Sciences (85)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (440)
  • Capital Markets (252)
  • Compliance, Sanctions and Risk (161)
  • Corporate and M&A (889)
  • Corporate Investigations (32)
  • Criminal Law and Enforcement (152)
  • Employment, Benefits and Pensions (426)
  • Energy, Industry and Climate (323)
  • Environment and Planning (926)
  • ESG & Sustainability (316)
  • EU and Competition Law (489)
  • Financial Regulation (180)
  • Infrastructure and Mobility (206)
  • Insurance (36)
  • Intellectual Property (121)
  • Investment Funds (148)
  • Litigation and Arbitration (441)
  • Mass Litigation (92)
  • Privacy and Data Protection (206)
  • Private Equity (198)
  • Procurement Law (127)
  • Public Law (1231)
  • Real Estate (492)
  • Restructuring and Insolvency (116)
  • Sports (27)
  • Tax (460)
  • Tech (197)
  • Technology, Media and Telecommunications (340)
  • Unfair Competition and Consumer Protection (200)
Jurisdiction
  • BE Law (23)
  • EU Law (14)
  • LU Law (7)
  • NL Law (59)
Language
  • Dutch (13)
  • English (88)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information